The BLUEPRINT Consortium was assembled with the aim of bringing together the most competitive and complementary European groups able to generate and analyse the epigenomes of haematopoietic cells in health and disease. The consortium consists of 41 partners organisations, representing 43 academic groups and 9 companies (mostly Small and Medium Enterprises (SMEs)) from 11 countries.